Exchangeable Zinc Pool Size and Zn Absorption From Sprinkles and Traditional Foods in Pakistani Infants /Toddlers
NCT ID: NCT01541696
Last Updated: 2018-06-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
40 participants
OBSERVATIONAL
2010-06-30
2012-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Zinc and / or Micronutrient Supplementation on Intestinal Flora, Diarrheal Disease Burden, Intestinal Mucosal Integrity and Growth Among Children of Pakistan
NCT00705445
Comparing the Efficacy of Different Zinc Formulations in the Treatment of Diarrhea
NCT00682955
Effect of Zinc Supplementation on Response to Oral Polio Vaccine in Infants in Pakistan
NCT01229579
Zinc Plus Saccharomyces Boulardii Versus Zinc Alone in the Treatment of Acute Diarrhea
NCT07168304
Water-based Zinc Efficacy Trial in Beninese Shool Children
NCT01790321
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The specific aim of the nested study will :
1. Determine absorption of zinc (Zn) from a test meal consisting of typical local food with addition of a multiple-micronutrient Sprinkles product containing (10 mg of Zn) vs absorption from the same meal without zinc supplementation to those with no micronutrient fortification.
2. Compare size of exchangeable Zn pool (EZP) for subjects who have been randomized to receive multi-micronutrient Sprinkle (MN) only with those who were randomized to (MN+Zn ) with control group.
3. Children will be followed for growth monitoring for at least 2 years.
4. Plasma zinc and phytates levels in the weaning diet will also be assessed.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group B
subjects in this group will receive Micronutrient Supplements only.
No interventions assigned to this group
Group C
Subjects in this Group will receive Micronutrient Supplements plus Zinc.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Infants who are currently recruited in the main zinc gates study and consuming sprinkles sachet containing micronutrient and zinc .
Exclusion Criteria
* Infants not on weaning diet
* Infants not consuming sprinkles sachet containing micronutrients
9 Months
12 Months
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Colorado, Denver
OTHER
International Atomic Energy Agency
OTHER_GOV
Bill and Melinda Gates Foundation
OTHER
Aga Khan University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr Shabina Ariff
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sajid B Soofi, MBBS, FCPS
Role: PRINCIPAL_INVESTIGATOR
Aga Khan University
Shabina Ariff, MBBS, FCPS
Role: STUDY_DIRECTOR
Aga Khan University
Zulfiqar A Bhutta, PhD
Role: STUDY_CHAIR
Aga Khan University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Bilal Colony
Karachi, Sindh, Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1387-PED-ERC-09
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.